G407002

Gleevec-d8 Mesylate (Imatinib-d8 Mesylate)

1092942-83-0

4696.50 €

HY-132386S

Imatinib-d8 (mesylate)

Imatinib-d8 (mesylate) is the deuterium labeled Imatinib mesylate[1].

Ask for quotation

HY-15463S

Imatinib-d8

Imatinib-d8 is a deuterium labeled Imatinib (STI571). Imatinib is an orally bioavailable tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity[1][2].

1574.12 €

I267983

Imatinib-D8 Hydrochloride

2830.02 €

A1805-100

Imatinib Mesylate (STI571)

TGF-β / Smad Signaling|Bcr-Abl#Tyrosine Kinase|Bcr-Abl#Tyrosine Kinase|c-Kit#Tyrosine Kinase|PDGFR

338.35 €

A1805-5.1

Imatinib Mesylate (STI571)

TGF-β / Smad Signaling|Bcr-Abl#Tyrosine Kinase|Bcr-Abl#Tyrosine Kinase|c-Kit#Tyrosine Kinase|PDGFR

350.47 €